Loading…

Autotransfusion during extracorporeal membrane oxygenation

To reduce allogeneic blood transfusion requirements during extracorporeal membrane oxygenation (ECMO) we evaluated an autotransfusion device which processes and retransfuses erythrocytes of changed ECMO-systems. We studied 10 elective changes of ECMO-systems in 7 patients. Hemoglobin levels, the amo...

Full description

Saved in:
Bibliographic Details
Published in:International journal of artificial organs 2000-12, Vol.23 (12), p.840-844
Main Authors: Tolksdorf, B, Schmeck, J, Osika, A, Bender, H J, Quintel, M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463
cites cdi_FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463
container_end_page 844
container_issue 12
container_start_page 840
container_title International journal of artificial organs
container_volume 23
creator Tolksdorf, B
Schmeck, J
Osika, A
Bender, H J
Quintel, M
description To reduce allogeneic blood transfusion requirements during extracorporeal membrane oxygenation (ECMO) we evaluated an autotransfusion device which processes and retransfuses erythrocytes of changed ECMO-systems. We studied 10 elective changes of ECMO-systems in 7 patients. Hemoglobin levels, the amount of retransfused autologous blood and of transfused allogeneic packed red blood cell units were documented within 48 h after the system change and compared to the measurements obtained from former ECMO-system changes without using any autotransfusion device. We determined the Horrowitz-index, Interleukin 6, 10, TNF-alpha and endothelin-I concentrations and coagulation parameters during the 48 hours after system change to study the compatibility of this procedure. Allogeneic blood transfusion was reduced from 7 to 2 units of packed red cells using the autotransfusion device. Additionally, no hints of any harmful side effects in these patients was observed.
doi_str_mv 10.1177/039139880002301210
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72537184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72537184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463</originalsourceid><addsrcrecordid>eNplkE1Lw0AURQdRbK3-AReSlbvoezOTTMZdKX5BwY2uw0zyUiJJps4k0P57p7TgwtWDx7mXy2HsFuEBUalHEBqFLgoA4AKQI5yxOSou0xwknLP5AUgPxIxdhfANgLmU2SWbIaJWSso5e1pOoxu9GUIzhdYNST35dtgktIvPyvmt82S6pKfeRogSt9tvaDBjRK_ZRWO6QDenu2BfL8-fq7d0_fH6vlqu04prPaaN4RoMAaGoc26UJI0FKgEyl01tC97kFmVcY0VWW0NC2xxFlVUiQxkhsWD3x96tdz8ThbHs21BR18U9bgql4plQWMgI8iNYeReCp6bc-rY3fl8ilAdj5X9jMXR3ap9sT_Vf5KRI_AIHJ2Xe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72537184</pqid></control><display><type>article</type><title>Autotransfusion during extracorporeal membrane oxygenation</title><source>Sage Journals Online</source><creator>Tolksdorf, B ; Schmeck, J ; Osika, A ; Bender, H J ; Quintel, M</creator><creatorcontrib>Tolksdorf, B ; Schmeck, J ; Osika, A ; Bender, H J ; Quintel, M</creatorcontrib><description>To reduce allogeneic blood transfusion requirements during extracorporeal membrane oxygenation (ECMO) we evaluated an autotransfusion device which processes and retransfuses erythrocytes of changed ECMO-systems. We studied 10 elective changes of ECMO-systems in 7 patients. Hemoglobin levels, the amount of retransfused autologous blood and of transfused allogeneic packed red blood cell units were documented within 48 h after the system change and compared to the measurements obtained from former ECMO-system changes without using any autotransfusion device. We determined the Horrowitz-index, Interleukin 6, 10, TNF-alpha and endothelin-I concentrations and coagulation parameters during the 48 hours after system change to study the compatibility of this procedure. Allogeneic blood transfusion was reduced from 7 to 2 units of packed red cells using the autotransfusion device. Additionally, no hints of any harmful side effects in these patients was observed.</description><identifier>ISSN: 0391-3988</identifier><identifier>EISSN: 1724-6040</identifier><identifier>DOI: 10.1177/039139880002301210</identifier><identifier>PMID: 11197744</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Blood Transfusion, Autologous ; Equipment Design ; Extracorporeal Membrane Oxygenation - instrumentation ; Extracorporeal Membrane Oxygenation - methods ; Hemoglobins ; Humans ; Interleukins - blood ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>International journal of artificial organs, 2000-12, Vol.23 (12), p.840-844</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463</citedby><cites>FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11197744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tolksdorf, B</creatorcontrib><creatorcontrib>Schmeck, J</creatorcontrib><creatorcontrib>Osika, A</creatorcontrib><creatorcontrib>Bender, H J</creatorcontrib><creatorcontrib>Quintel, M</creatorcontrib><title>Autotransfusion during extracorporeal membrane oxygenation</title><title>International journal of artificial organs</title><addtitle>Int J Artif Organs</addtitle><description>To reduce allogeneic blood transfusion requirements during extracorporeal membrane oxygenation (ECMO) we evaluated an autotransfusion device which processes and retransfuses erythrocytes of changed ECMO-systems. We studied 10 elective changes of ECMO-systems in 7 patients. Hemoglobin levels, the amount of retransfused autologous blood and of transfused allogeneic packed red blood cell units were documented within 48 h after the system change and compared to the measurements obtained from former ECMO-system changes without using any autotransfusion device. We determined the Horrowitz-index, Interleukin 6, 10, TNF-alpha and endothelin-I concentrations and coagulation parameters during the 48 hours after system change to study the compatibility of this procedure. Allogeneic blood transfusion was reduced from 7 to 2 units of packed red cells using the autotransfusion device. Additionally, no hints of any harmful side effects in these patients was observed.</description><subject>Adult</subject><subject>Blood Transfusion, Autologous</subject><subject>Equipment Design</subject><subject>Extracorporeal Membrane Oxygenation - instrumentation</subject><subject>Extracorporeal Membrane Oxygenation - methods</subject><subject>Hemoglobins</subject><subject>Humans</subject><subject>Interleukins - blood</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0391-3988</issn><issn>1724-6040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNplkE1Lw0AURQdRbK3-AReSlbvoezOTTMZdKX5BwY2uw0zyUiJJps4k0P57p7TgwtWDx7mXy2HsFuEBUalHEBqFLgoA4AKQI5yxOSou0xwknLP5AUgPxIxdhfANgLmU2SWbIaJWSso5e1pOoxu9GUIzhdYNST35dtgktIvPyvmt82S6pKfeRogSt9tvaDBjRK_ZRWO6QDenu2BfL8-fq7d0_fH6vlqu04prPaaN4RoMAaGoc26UJI0FKgEyl01tC97kFmVcY0VWW0NC2xxFlVUiQxkhsWD3x96tdz8ThbHs21BR18U9bgql4plQWMgI8iNYeReCp6bc-rY3fl8ilAdj5X9jMXR3ap9sT_Vf5KRI_AIHJ2Xe</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>Tolksdorf, B</creator><creator>Schmeck, J</creator><creator>Osika, A</creator><creator>Bender, H J</creator><creator>Quintel, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001201</creationdate><title>Autotransfusion during extracorporeal membrane oxygenation</title><author>Tolksdorf, B ; Schmeck, J ; Osika, A ; Bender, H J ; Quintel, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Blood Transfusion, Autologous</topic><topic>Equipment Design</topic><topic>Extracorporeal Membrane Oxygenation - instrumentation</topic><topic>Extracorporeal Membrane Oxygenation - methods</topic><topic>Hemoglobins</topic><topic>Humans</topic><topic>Interleukins - blood</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tolksdorf, B</creatorcontrib><creatorcontrib>Schmeck, J</creatorcontrib><creatorcontrib>Osika, A</creatorcontrib><creatorcontrib>Bender, H J</creatorcontrib><creatorcontrib>Quintel, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tolksdorf, B</au><au>Schmeck, J</au><au>Osika, A</au><au>Bender, H J</au><au>Quintel, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autotransfusion during extracorporeal membrane oxygenation</atitle><jtitle>International journal of artificial organs</jtitle><addtitle>Int J Artif Organs</addtitle><date>2000-12-01</date><risdate>2000</risdate><volume>23</volume><issue>12</issue><spage>840</spage><epage>844</epage><pages>840-844</pages><issn>0391-3988</issn><eissn>1724-6040</eissn><abstract>To reduce allogeneic blood transfusion requirements during extracorporeal membrane oxygenation (ECMO) we evaluated an autotransfusion device which processes and retransfuses erythrocytes of changed ECMO-systems. We studied 10 elective changes of ECMO-systems in 7 patients. Hemoglobin levels, the amount of retransfused autologous blood and of transfused allogeneic packed red blood cell units were documented within 48 h after the system change and compared to the measurements obtained from former ECMO-system changes without using any autotransfusion device. We determined the Horrowitz-index, Interleukin 6, 10, TNF-alpha and endothelin-I concentrations and coagulation parameters during the 48 hours after system change to study the compatibility of this procedure. Allogeneic blood transfusion was reduced from 7 to 2 units of packed red cells using the autotransfusion device. Additionally, no hints of any harmful side effects in these patients was observed.</abstract><cop>United States</cop><pmid>11197744</pmid><doi>10.1177/039139880002301210</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0391-3988
ispartof International journal of artificial organs, 2000-12, Vol.23 (12), p.840-844
issn 0391-3988
1724-6040
language eng
recordid cdi_proquest_miscellaneous_72537184
source Sage Journals Online
subjects Adult
Blood Transfusion, Autologous
Equipment Design
Extracorporeal Membrane Oxygenation - instrumentation
Extracorporeal Membrane Oxygenation - methods
Hemoglobins
Humans
Interleukins - blood
Tumor Necrosis Factor-alpha - metabolism
title Autotransfusion during extracorporeal membrane oxygenation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autotransfusion%20during%20extracorporeal%20membrane%20oxygenation&rft.jtitle=International%20journal%20of%20artificial%20organs&rft.au=Tolksdorf,%20B&rft.date=2000-12-01&rft.volume=23&rft.issue=12&rft.spage=840&rft.epage=844&rft.pages=840-844&rft.issn=0391-3988&rft.eissn=1724-6040&rft_id=info:doi/10.1177/039139880002301210&rft_dat=%3Cproquest_cross%3E72537184%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c299t-fa290ae0e13d62a74e9181730464fdb82f6b14774b35dbae39b613c5c35140463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72537184&rft_id=info:pmid/11197744&rfr_iscdi=true